Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
The latest available 13F covers holdings as of Jun 30, 2026 (Q2 2026) and was filed Aug 14, 2026. Quarter-end snapshot, not a live trade.
Disclosed 13F value
$21.5B
sum of reported positions
Reported positions
85
Changes vs prior quarter
178
21 new · 107 exited
Filings on record
9
Q2 2026, Q1 2026, Q4 2025, Q3 2025, Q2 2025, Q1 2025, Q4 2024, Q3 2024, Q2 2024
Across 123 measured positions in 8 quarters, the typical new or larger position finished −4.8 pts against the S&P 500 and 42% finished ahead of it. For scale, across all 501 funds with a result: −2.2 pts typical, 44% ahead.
Measured on each position this fund reported as new or larger, from the first close after the filing became public, against the S&P 500, 90 days later. Sales are not scored. History, not a forecast; it shows what the stocks did, not what the fund knew.
Total value of the 13F each quarter. It moves with prices as well as with what the fund bought or sold, so a rise is not necessarily a purchase.
| Company | Shares | Value | Weight |
|---|---|---|---|
STATE STR SPDR S&P 500 ETF TPUT | 6M | $4.48B | 20.8% |
| 13.6M | $2.54B | 11.8% | |
ELECTRONIC ARTS INC | 7.92M | $1.62B | 7.5% |
| 10.7M | $800M | 3.7% | |
Comparison uses this manager's immediately preceding 13F-HR. Puts and calls are separate lines. Share counts drive classification; reported value also moves with price.Methodology
Change in the reported value against the quarter before.
Weights are within the disclosed 13F portfolio, for the ten largest lines.
| Q1 2026 | Q2 2026 | |
|---|---|---|
| Reported value | $19B | $21.5B |
| Positions | 171 | 85 |
| Biggest line | — | STATE STR SPDR S&P 500 ETF T 21% |
| 6.35M |
| $778M |
| 3.6% |
| 13.5M | $733M | 3.4% |
| 8.37M | $667M | 3.1% |
| 2.63M | $628M | 2.9% |
| 5.58M | $619M | 2.9% |
| 2.22M | $602M | 2.8% |
| 1.27M | $528M | 2.5% |
| 1.05M | $526M | 2.4% |
| 14.3M | $506M | 2.4% |
| 1.38M | $459M | 2.1% |
| 10.5M | $449M | 2.1% |
| 1.15M | $435M | 2.0% |
| 1.11M | $415M | 1.9% |
| 12.3M | $384M | 1.8% |
| 4.12M | $378M | 1.8% |
| 830K | $370M | 1.7% |
| 10.2M | $351M | 1.6% |
CRINETICS PHARMACEUTICALS IN | 8.99M | $336M | 1.6% |
| 4.16M | $284M | 1.3% |
| 895K | $241M | 1.1% |
| 5.8M | $224M | 1.0% |
Disney (DIS)
2.4M shares in Q1 2026
STATE STR SPDR S&P 500 ETF T · PUT
2.3M shares in Q1 2026
Vaxcyte (PCVX)
1.26M shares in Q1 2026
Opus Genetics (IRD)
1M shares in Q1 2026
Alphabet (GOOGL)
996K shares in Q1 2026
Visa (V)
841K shares in Q1 2026
Dianthus Therapeutics, Inc. (DNTH)
836K shares in Q1 2026
Cg Oncology (CGON)
674K shares in Q1 2026
Inter & (INTR)
615K shares in Q1 2026
BITWISE 10 CRYPTO INDEX ETF
603K shares in Q1 2026
Royalty Pharma (RPRX)
493K shares in Q1 2026
Tenet Health (THC)
452K shares in Q1 2026
Mastercard (MA)
435K shares in Q1 2026
Cardinal Health (CAH)
368K shares in Q1 2026
Atrium Therapeutics (RNA)
349K shares in Q1 2026
Gds Holdings (GDS)
292K shares in Q1 2026
Garrett Motion (GTX)
275K shares in Q1 2026
Tenable Holdings (TENB)
265K shares in Q1 2026
McKesson Corporation (MCK)
234K shares in Q1 2026
Ceco Environmental (CECO)
234K shares in Q1 2026
CG ONCOLOGY INC · CALL
200K shares in Q1 2026
Affirm Holdings (AFRM)
108K shares in Q1 2026
Globalfoundries (GFS)
105K shares in Q1 2026
Amkor Technology (AMKR)
104K shares in Q1 2026
Rollins, Inc. (ROL)
93K shares in Q1 2026
